Topics, Categories, Guidelines

Submit your most challenging cases in valvular and structural heart disease. The best submissions will be selected for presentation at TVT.

Guidelines

Please submit a PowerPoint file of about five to 10 slides.

The following video formats are allowed: mpeg, wmv, avi, mov, mpg & mp4.
All videos should be under 30 MB.

Upload .png, .jpg files only
Upload limit per image is 10 MB

Submit your novel technology concepts for a chance to present at the TVT Innovation Forum. The annual TVT meeting is the preeminent platform for unveiling new technological developments in transcatheter valve therapies, LAA closure, PFO closure, and other structural heart disease therapies.

Submissions must be relevant to the monitoring, diagnosis, or treatment of valvular heart disease and interventions.

Presenters will be notified via email if their presentations are selected to be featured in the TVT Innovation Forum or other TVT sessions.

Guidelines

Please submit a PowerPoint file of about 10 to 15 slides. Your submission must include all of the following as they relate to your technology:

• Unmet clinical need it fills/its intended field of use.
• Description of the technology and differentiation from existing technologies.
• IP position/landscape.
• Summary of preclinical and/or early human data (if appropriate).
• Regulatory pathway/strategy and strategy for commercialization (if appropriate).

Submit your late-breaking clinical science for presentation at TVT. Submissions should be first-time presentations of any of the following:

• The primary endpoint or major secondary endpoint results of a randomized clinical trial or registry.
• Insightful meta-analysis that may have an impact on clinical practice.
• Early human clinical experience with novel devices.

Important: Late-breaking clinical science presentations that have been accepted are subject to strict embargo before they are officially presented at TVT 2023.

Guidelines

• Limit of 3,000 characters, including spaces and including characters in images and tables.
• Text fields include full trial summary and primary endpoint data.
• Upload limit per image is 10 MB.
• Please submit .PNG and .JPG files only.

A Message for Accepted Late-Breaking Clinical Science presenters

We also wish to extend an invitation to submit the final paper of your work to Structural Heart: The Journal of the Heart Team, the official journal of the Cardiovascular Research Foundation. We will give your submission expedited review and, if accepted, simultaneous publication online at https://www.structuralheartjournal.org/ ahead of formal inclusion in an upcoming issue of the journal. We can also offer support publicizing your science through press and social media promotion. For more information contact Maria Alu ([email protected]).

Submit abstracts that address:

• Valvular disease or transcatheter valve interventions.
• LAA or PFO closure.
• Other structural heart disease diagnostic modalities or therapies.

Entries must be original research but may include portions of prior abstracts and/or manuscripts presented elsewhere. Clinical studies, basic science investigations, and preclinical studies are equally encouraged.

Guidelines

Limit of 2,200 characters, including spaces and including characters in images and tables.

A Message for Accepted Abstract presenters

We also wish to extend an invitation to submit the final paper of your work to Structural Heart: The Journal of the Heart Team, the official journal of the Cardiovascular Research Foundation. We will give your submission expedited review and, if accepted, simultaneous publication online at https://www.structuralheartjournal.org/ ahead of formal inclusion in an upcoming issue of the journal. We can also offer support publicizing your science through press and social media promotion. For more information contact Maria Alu ([email protected]).

Fellows, you are invited to submit challenging cases that convey important teaching points related to structural heart disease interventions, specifically including the following:

• TAVR
• TMVr (MitraClip)
• TMVR (V-in-V)
• PVL closure
• LAAO

Your submission may relate to patient management, procedural planning, case conduct, or complications. Common clinical scenarios and challenges are favored over rare diseases and unusual procedures or complications.

Eligibility

All current fellows in training, including cardiology fellows, interventional cardiology fellows, and advanced interventional cardiology fellows (structural heart, CHIP, research, etc).

Guidelines

• Five-minute PowerPoint presentation.
• Include two to three minutes for each of the following:
  • Case presentation.
  • Case resolution.